The ProLon Fasting Mimicking Diet is considered by many thought leaders the biggest breakthrough in nutrition of this Century. ProLon is a natural, plant-based diet where users consume a proprietary blend of high quality foods and nutrients that allow the body to go into, and get the benefits of, “Fasting Mode”. This is how the ‘Fasting Mimicking’ invention came to be.
Los Angeles, Calif.—July 31, 2018—On July 10, L-Nutra, Inc. became the first company to market a product that has been granted a patent by the United States Patent and Trademark Office (USPTO) for optimizing human healthspan, the length of time that a person is healthy. This follows a landmark patent issued in 2016 for treating diabetes and multiple patents previously issued for cancer treatment, but this is the first patented protocol to address health and wellness prior to the onset of disease. The patent is for the Fasting Mimicking Diet® (FMD®), discovered and clinically tested by the laboratory of Valter Longo and Keck Hospital at the University of Southern California (USC), a nutrition technology that is proven to reduce markers for age-related disease as well as promote tissue regeneration.
About L-Nutra, Inc.
L-Nutra’s team of researchers and collaborators are leaders in the field of nutrition related to longevity and healthspan. L-Nutra has the exclusive rights from the University of Southern California to market ProLon® and other FMD®s, which mimic and enhance the effects of fasting, unleash the body’s natural ability to rejuvenate itself, and promote healthy longevity. These nutri-technologies are the result of decades of lab and clinical research to demonstrate safety and efficacy. For more information, please visit l-nutra.com and prolonfmd.com.